Clients call Neil when complex government regulations or decisions threaten their company’s future by jeopardizing transactions, mergers, acquisitions, licenses, new product applications enforcement proceedings, administrative actions, litigation, stalled applications or civil and criminal investigations and complaints.
Neil’s practice focuses on a wide array of regulatory and compliance issues in the pharmaceutical, biologic, supplement, and medical device industries (and related data privacy and security regulatory issues). Neil also advises on many business transactions and filings for FDA regulated products and companies.
For over two decades, Neil has helped his clients navigate complex government regulations or decisions that impact their future. He has advised all types of life sciences companies on a broad range of U.S. and international regulatory compliance challenges and issues that arise in government regulatory approvals and actions, transactions, mergers, acquisitions, licensing, products liability litigation and other disputes.